Researchers in England say drug can reduce death rates in very ill COVID-19 patients. But it's risky for those with mild symptoms.
— has proved effective in a rigorous clinical trial, but its benefit was limited to shortened recovery time.
The steroid “is the first drug to be shown to improve survival in COVID-19,” said Oxford University’san infectious-diseases expert and one of the clinical trial’s chief investigators. “The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients.”
, director of Emory University’s critical care center. For patients with such a high risk of dying, a one-third reduction in mortality is “remarkable,” he said. At the same time, physicians responded cautiously to the glowing study findings that were summarized in a news release rather than published in detail in a medical journal, as is customary.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dexamethasone Improves Survival in Severe Covid-19 Patients, Study FindsA generic steroid drug is the first to show in a clinical trial it could improve the survival of severely ill coronavirus patients, University of Oxford researchers said
Read more »
Coronavirus: Dexamethasone can improve COVID-19 survival, study saysResearchers in England say they have the first evidence that a drug can improve chances of survival from COVID-19.
Read more »
Cheap, widely available steroid called dexamethasone improves COVID survival, researchers sayA cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients.
Read more »
Common steroid found to reduce deaths in sickest COVID-19 patients, researchers sayBREAKING: A common steroid drug has been shown to reduce deaths by a third in the sickest patients in the hospital with COVID-19, British scientists say, the first time a drug has been shown to have an effect on death rates of the virus.
Read more »
Transmission of COVID-19 to Baby During Birth Is Uncommon, Study SaysRead about a new systematic review of 49 studies from the University of Nottingham that found transmission from mom to baby during birth and breastfeeding is relatively uncommon.
Read more »
Study showing teens less likely to catch Covid-19 may mean school can reopen, expert saysA study showing that children and teens are half as likely as adults to become infected with coronavirus might be good news for schools seeking to reopen, a former top health policy adviser to former President Obama said
Read more »